Latest Conference Coverage


Recapping Research From 2023 AHS Annual Scientific Meeting

Recapping Research From 2023 AHS Annual Scientific Meeting

June 29th 2023

As a recap from AHS 2023, get caught up on some of the latest news in neurology as the NeurologyLive® team shares some of our data updates.


Future Research on Cannabis Use to Treat Migraine: Nathaniel Schuster, MD

Future Research on Cannabis Use to Treat Migraine: Nathaniel Schuster, MD

June 29th 2023

The pain management specialist and headache neurologist at the University of California San Diego Center for Pain Medicine discussed the different forms of cannabis and the need to conduct larger, multicenter studies to better understand its effects in migraine. [WATCH TIME: 3 minutes]


Rethinking Treatment and Measurements of Fatigue in Multiple Sclerosis

Rethinking Treatment and Measurements of Fatigue in Multiple Sclerosis

June 29th 2023

John DeLuca, PhD, senior vice president for Research and Training at Kessler Foundation, discussed the challenges in understanding and measuring fatigue in patients with multiple sclerosis.


Recapping Research From 2023 CMSC Annual Meeting

Recapping Research From 2023 CMSC Annual Meeting

June 28th 2023

As a recap from CMSC 2023, get caught up on some of the latest news in neurology as the NeurologyLive® team shares some of our data updates.


Keys Clinicians Should Consider When Designing Equitable Courses: Alexandria Reynolds, PhD

Keys Clinicians Should Consider When Designing Equitable Courses: Alexandria Reynolds, PhD

June 28th 2023

The undergraduate program director at the University of South Carolina provided perspective on the factors that go into building an equitable and effective medical course for young medical professionals. [WATCH TIME: 5 minutes]


Clinical Utility of Neurofilament Light in Older Adults With Sleep Disorders: Junxin Li, PhD, MS, RN, FAAN

Clinical Utility of Neurofilament Light in Older Adults With Sleep Disorders: Junxin Li, PhD, MS, RN, FAAN

June 28th 2023

The associate professor at Johns Hopkins School of Nursing provided insight on a presentation at SLEEP 2023, and whether neurofilament light should be more considered when assessing elderly patients with sleep disorders. [WATCH TIME: 5 minutes]


NeuroVoices: Burel Goodin, PhD, on Improving Pain Medicine Care in Underserved Populations

NeuroVoices: Burel Goodin, PhD, on Improving Pain Medicine Care in Underserved Populations

June 28th 2023

The professor of anesthesiology at Washington University in St. Louis provided insight on his presentation at AHS 2023 discussing the need to engage underserved populations.


Gaining a Better Understanding of Idiopathic Hypersomnia, Uses of Low-Sodium Oxybate

Gaining a Better Understanding of Idiopathic Hypersomnia, Uses of Low-Sodium Oxybate

June 27th 2023

Marisa Whalen, PharmD, associate director of Medical Affairs at Jazz Pharmaceuticals, discussed presentations at SLEEP 2023 on the real-world burdens of idiopathic hypersomnia and the smooth transition to low sodium oxybate in patients with narcolepsy.


Patient Perspectives and the Importance of Advocacy and Support in Parkinson Disease: Lori DePorter

Patient Perspectives and the Importance of Advocacy and Support in Parkinson Disease: Lori DePorter

June 26th 2023

At ATMRD 2023, Lori DePorter, global ambassador for the PMD alliance, talked from the patient experience about the need for improved communication between care teams and support groups in Parkinson disease. [WATCH TIME: 3 minutes]


Efforts to Overcome Sleep Issues in Underserved Communities: Dayna Johnson, PhD, MPH, MSW, MS

Efforts to Overcome Sleep Issues in Underserved Communities: Dayna Johnson, PhD, MPH, MSW, MS

June 26th 2023

The sleep epidemiologist and assistant professor at the Rollins School of Public Health at Emory University discussed the multi-level effort needed to improve sleep issues seen in individuals most impacted by social determinants of health. [WATCH TIME: 3 minutes]


Tension-Type Headache, An Understudied and Undertreated Condition: Sait Ashina, MD, FAHS

Tension-Type Headache, An Understudied and Undertreated Condition: Sait Ashina, MD, FAHS

June 25th 2023

The assistant professor of neurology at Harvard Medical School talked about the prevalence of tension-type headache and how recent advances shed light on its pathophysiological mechanisms, leading to potential new treatments for the condition. [WATCH TIME: 5 minutes]


Clinical Implications on the Influence of the Microbiome on Migraine Regulation: Blanca Marquez de Prado, PhD

Clinical Implications on the Influence of the Microbiome on Migraine Regulation: Blanca Marquez de Prado, PhD

June 23rd 2023

The research project manager of the headache program at the Children's Hospital of Philadelphia discussed data that suggest that an unhealthy and imbalanced microbiome may exacerbate the frequency, severity, and duration of migraines. [WATCH TIME: 4 minutes]


Gut-Brain Interaction, the Overlapping Connection Between Cyclic Vomiting and Migraine

Gut-Brain Interaction, the Overlapping Connection Between Cyclic Vomiting and Migraine

June 23rd 2023

B U. K. Li, MD, emeritus professor of pediatrics and gastroenterology at the Medical College of Wisconsin, highlights the significant overlap between cyclic vomiting syndrome, abdominal migraine, and migraine headaches.


Benefits and Risks of Opioid Use in Restless Legs Syndrome: John Winkelman, MD, PhD

Benefits and Risks of Opioid Use in Restless Legs Syndrome: John Winkelman, MD, PhD

June 22nd 2023

The chief of the Sleep Disorders Clinical Research Program at Massachusetts General Hospital discussed the benefits opioids have for patients with restless legs syndrome, as well as how they can be safely used as part of treatment strategies. [WATCH TIME: 4 minutes]


Fremanezumab Significantly Reduces in Depression in Patients With Migraine and Major Depressive Disorder

Fremanezumab Significantly Reduces in Depression in Patients With Migraine and Major Depressive Disorder

June 22nd 2023

Over an 8-week period, patients with migraine and major depressive disorder who were treated with fremanezumab showed significant reductions in HAMD-17 and PHQ-9 scores.


Exploring the Potential Associations Between Migraine and Dementia: Olivia Begasse de Dhaem, MD, FAHS

Exploring the Potential Associations Between Migraine and Dementia: Olivia Begasse de Dhaem, MD, FAHS

June 22nd 2023

The headache specialist at Hartford Healthcare Headache Center talked about her debate at AHS 2023 on why migraine is not a risk factor for dementia. [WATCH TIME: 5 minutes]


Insights on Sunobinop As a Treatment for Insomnia in Patients Recovering From Alcohol Use Disorder

Insights on Sunobinop As a Treatment for Insomnia in Patients Recovering From Alcohol Use Disorder

June 22nd 2023

Garth T. Whiteside, PhD, head of preclinical development at Imbrium Therapeutics, discussed a phase 2 clinical study that explored the use of sunobinop in patients with insomnia during recovery from alcohol use disorder.


Galcanezumab Shows Greatest Reduction in Disease Burden Following Switching

Galcanezumab Shows Greatest Reduction in Disease Burden Following Switching

June 21st 2023

Following the initiation or switch to a new migraine preventive medication, patients taking galcanezumab showed numerically greater 3-month improvements for most measures of health-related quality of life and disability.


Management and Impact of Migraine During Pregnancy: Rashmi Halker Singh, MD

Management and Impact of Migraine During Pregnancy: Rashmi Halker Singh, MD

June 21st 2023

The associate professor of neurology at Mayo Clinic discussed the developing field of migraine management during pregnancy and the importance of raising awareness of treatment options during the gestation period. [WATCH TIME: 4 minutes]


NeuroVoices: Sara Pavitt, MD, on the Need to Educate the Clinical Community on Pediatric Headache

NeuroVoices: Sara Pavitt, MD, on the Need to Educate the Clinical Community on Pediatric Headache

June 21st 2023

At the 2023 AHS Annual Meeting, the chief of headache at UT Austin Dell Children’s Hospital discussed her presentation on a new educational intervention to improve knowledge of pediatric headache.


Increased Efficacy Through Combination of Remote Electrical Neuromodulation and Gepants

Increased Efficacy Through Combination of Remote Electrical Neuromodulation and Gepants

June 20th 2023

The combination of both REN and gepants for acute migraine treatment may have an increased efficacy compared with REN alone, an expected result based on the different actions of the treatments.


Using an Integrated EHR Questionnaire to Improve Diagnosis and Treatment in Pediatric Headache: Christina Szperka, MD, MSCE

Using an Integrated EHR Questionnaire to Improve Diagnosis and Treatment in Pediatric Headache: Christina Szperka, MD, MSCE

June 20th 2023

The director of the Pediatric Headache Program at the Children’s Hospital of Philadelphia talked about the usage of an integrated EHR questionnaire to improve the likelihood of specific diagnosis in pediatric headache. [WATCH TIME: 5 minutes]


Approach to Cannabis and Optimizing Treatment for Migraine: Nathaniel Schuster, MD

Approach to Cannabis and Optimizing Treatment for Migraine: Nathaniel Schuster, MD

June 19th 2023

The pain management specialist and headache neurologist at the University of California San Diego Center for Pain Medicine provided perspective on how cannabis may be used in the management of migraine as more evidence is uncovered. [WATCH TIME: 3 minutes]


Zavegepant Tolerable, Safe When Used in Combination With Other CGRP Monoclonal Antibodies

Zavegepant Tolerable, Safe When Used in Combination With Other CGRP Monoclonal Antibodies

June 19th 2023

Data showed similar rates of discontinuation because of adverse events between those with and without CGRP monoclonal antibodies, as well as no serious AEs observed for those on concomitant medication.


Unveiling the Connection Between Migraine and the Gut: Daping Yang, PhD

Unveiling the Connection Between Migraine and the Gut: Daping Yang, PhD

June 19th 2023

The postdoctoral researcher at Harvard Medical School discussed the relationship between sensory neurons and the neuropeptide CGRP in regulating gut immunity. [WATCH TIME: 6 minutes]


Intravenous Ketamine Significantly Reduces Pain in Refractory Pediatric Headache

Intravenous Ketamine Significantly Reduces Pain in Refractory Pediatric Headache

June 19th 2023

The use of intravenous ketamine in pediatric patients with refractory headaches resulted in a median pain reduction of 50% at discharge and nearly two-third of patients did not need further rescue therapies 1 month posttreatment.


Exploring Behavioral Approaches in Migraine Management: Elizabeth Seng, PhD

Exploring Behavioral Approaches in Migraine Management: Elizabeth Seng, PhD

June 19th 2023

The associate professor at Yeshiva University and Albert Einstein College of Medicine discussed the significance of recognizing the behavioral aspects of migraine management such as lifestyle choices, medical interventions, and societal influences. [WATCH TIME: 4 minutes]


How Retinal Imaging Reveals Alterations During Migraine Attacks: Katherine Podraza, MD, PhD

How Retinal Imaging Reveals Alterations During Migraine Attacks: Katherine Podraza, MD, PhD

June 18th 2023

The headache specialist at the Hartford Healthcare Headache Center discussed a study that explored changes in the vasculature and retinal blood perfusion of the eye during migraine attacks. [WATCH TIME: 5 minutes]

© 2023 MJH Life Sciences

All rights reserved.